Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Jim Miller

Outsourcing Outlook

http://www.pharmsource.com

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report, a monthly newsletter covering the contract drug development industry. A trial subscription can be obtained by calling 703.383.4903, by faxing 703.383.4905, by e-mailing info@pharmsource.com, or on the Web at www.pharmsource.com.

Articles
How Will CMO Ownership Changes Impact Market?
April 1, 2014

Changes in company ownership shake up the CMO industry.

Under New Ownership
March 2, 2014

Changes in company ownership shake up the CMO industry.

Evolving R&D Model Pressures Contract Services Market
January 31, 2014

The R&D model is in transition and creating new demands on contract services providers.

Climate Change Drives New Opportunities in Outsourcing
January 2, 2014

Ongoing changes create new opportunities for CROs and CMOs.

R&D in Transition
January 2, 2014

The R&D model is in transition and creating new demands on contract services providers.

Climate Change in Outsourcing
December 2, 2013

Ongoing changes create new opportunities for CROs and CMOs.

The Expense of Vision in Outsourcing
November 6, 2013

Practicality of implementation should be a part of vision in the bio/pharmaceutical industry.

The Expense of Vision in Outsourcing
October 2, 2013

Practicality of implementation should be a part of vision in the bio/pharmaceutical industry.

Outsourcing Partnerships for CMC Development
October 1, 2013

Are strategic partnerships in clinical research a model for CMC services?

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here